Philip Coxon

Executive Director, Business Development at Insmed

Speaker

Philip Coxon is a Senior Global Business Development Executive with over 15 years' experience across top-tier pharmaceutical and biotech companies, bringing a proven track record in strategic transactions, partnering, and alliance management. Currently Executive Director, Business Development at Insmed — a role he assumed following Insmed's acquisition of Adrestia Therapeutics, where he served as Vice President, Business Development and led the sale of the company — Philip drives external growth strategy, transaction execution, and senior-level partnerships. He previously held senior roles at AstraZeneca, leading global oncology deals exceeding $3 billion in value, and at Teva Pharmaceuticals and LifeArc. Philip holds a PhD in Developmental Biology from the Institute of Cancer Research, University of London, and BSc (Hons) in Biochemistry & Physiology from the University of Leeds.